Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1C | P00326 | 2/20 | 0.42 |
| ▸ | ADH1A | P07327 | 2/20 | 0.42 |
| ▸ | ADH4 | P08319 | 2/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.37 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.36 |
| ▸ | ZDHHC2 | Q9UIJ5 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 6/20 | 0.36 |
| ▸ | FAAH | O00519 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | ADH1B | P00325 | 1/20 | 0.33 |
| ▸ | ADH7 | P40394 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.31 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8087321 | 0.98 | ADH1C (0.46) | ADH1CADH1AADH4DNM1ZDHHC20 | |
| SCHEMBL5466491 | 0.98 | ADH1C (0.46) | ADH1CADH1AADH4DNM1ZDHHC20 | |
| SCHEMBL8087538 | 0.98 | ADH1C (0.46) | ADH1CADH1AADH4DNM1ZDHHC20 | |
| SCHEMBL8086267 | 0.98 | ADH1C (0.46) | ADH1CADH1AADH4DNM1ZDHHC20 | |
| SCHEMBL8087564 | 0.98 | ADH1C (0.46) | ADH1CADH1AADH4DNM1ZDHHC20 | |
| SCHEMBL3479785 | 0.98 | ADH1C (0.46) | ADH1CADH1AADH4DNM1ZDHHC20 | |
| SCHEMBL5461538 | 0.98 | ADH1C (0.46) | ADH1CADH1AADH4DNM1ZDHHC20 | |
| SCHEMBL2948526 | 0.93 | — | — | |
| SCHEMBL2180916 | 0.88 | — | — | |
| SCHEMBL7941252 | 0.85 | ADH1C (0.30) | ADH1CADH1AADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101873801-B | Systemicity enhancers | BASF SE | 2014-12-10 | — | — | CN | disclosed |
| CN-101873801-A | Systemicity enhancers | BASF SE | 2010-10-27 | — | — | CN | disclosed |
| US-20100204045-A1 | Systemicity Enhancers | BASF SE (DE) | 2010-08-12 | — | — | US | disclosed |
| EP-2205097-A1 | SYSTEMICITY ENHANCERS | BASF SE (DE) | 2010-07-14 | — | — | EP | disclosed |
| US-7666506-B2 | Surface-modified metal oxides prepared by precipitation in the presence of a copolymer having N-vinylamide units, production processes and use thereof in cosmetic preparations | BASF SE (DE) | 2010-02-23 | — | — | US | disclosed |
| WO-2009040248-A1 | SYSTEMICITY ENHANCERS | BASF SE (DE) | 2009-04-02 | — | — | WO | disclosed |
| EP-0972110-B2 | METHOD FOR PRODUCING HIGH DRY-STRENGTH PAPER, PULPBOARD AND CARDBOARD | BASF SE (DE) | 2009-03-11 | — | — | EP | disclosed |
| US-20080193759-A1 | Surface-Modified Metal Oxides, Production Processes And Use Thereof In Cosmetic Praparations | BASF AKTIENGESELLSCHAFT (DE) | 2008-08-14 | — | — | US | disclosed |
| US-20080153925-A1 | Use of Amphiphilic Copolymers as Solubilising Agents | BASF AKTIENGESELLSCHAFT (DE) | 2008-06-26 | — | — | US | disclosed |
| CN-101189307-A | Surface-modified metal oxides, method for production and use thereof in cosmetic preparations | BASF AG (DE) | 2008-05-28 | — | — | CN | disclosed |
| EP-0929285-A2 | USE OF WATER-SOLUBLE COPOLYMERS AS ACTIVE INGREDIENTS IN COSMETICS | BASF AKTIENGESELLSCHAFT (DE) | 1999-07-21 | — | — | EP | disclosed |
| US-5851300-A | Cationic modification of starch and use of the cationically modified starch | BASF AKTIENGESELLSCHAFT (DE) | 1998-12-22 | — | — | US | disclosed |
| WO-1998045536-A1 | METHOD FOR PRODUCING HIGH DRY-STRENGTH PAPER, PULPBOARD AND CARDBOARD | BASF AKTIENGESELLSCHAFT (DE) | 1998-10-15 | — | — | WO | disclosed |
| WO-1998041565-A1 | AQUEOUS DISPERSIONS OF REACTIVE GLUING AGENTS, METHOD FOR THE PRODUCTION, AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-24 | — | — | WO | disclosed |
| EP-0788516-B1 | CATIONIC MODIFICATION PROCESS FOR STARCH AND USE OF CATIONICALLY MODIFIED STARCH | BASF AG (DE) | 1998-07-29 | — | — | EP | disclosed |
| WO-1998031711-A1 | POLYMER-MODIFIED ANIONIC STARCH, METHOD FOR ITS PRODUCTION, AND ITS USE | BASF AKTIENGESELLSCHAFT (DE) | 1998-07-23 | — | — | WO | disclosed |
| WO-1998031740-A1 | POLYMER-MODIFIED STARCH, METHOD FOR ITS PRODUCTION, AND ITS USE | BASF AKTIENGESELLSCHAFT (DE) | 1998-07-23 | — | — | WO | disclosed |
| WO-1998014164-A2 | USE OF WATER-SOLUBLE COPOLYMERS AS ACTIVE INGREDIENTS IN COSMETICS | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-09 | — | — | WO | disclosed |
| EP-0788516-A1 | CATIONIC MODIFICATION PROCESS FOR STARCH AND USE OF CATIONICALLY MODIFIED STARCH | BASF AKTIENGESELLSCHAFT (DE) | 1997-08-13 | — | — | EP | disclosed |
| WO-1996013525-A1 | CATIONIC MODIFICATION PROCESS FOR STARCH AND USE OF CATIONICALLY MODIFIED STARCH | BASF AKTIENGESELLSCHAFT (DE) | 1996-05-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153925-A1 | Use of Amphiphilic Copolymers as Solubilising Agents | VCL, ASS1, CCNL2 | ADH1C 1288/4885ADH1A 1309/4885ADH4 2473/4885 |
| US-20100204045-A1 | Systemicity Enhancers | C3AR1, C5, CHRM1 | ADH1C 613/4885ADH1A 889/4885ADH4 2548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.